Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire Axonics, Inc. (Nasdaq: AXNX), a leading medical technology company specializing in urinary and bowel dysfunction devices. The acquisition, valued at $71 per share in cash, reflects an equity value of approximately $3.7 billion and an enterprise value of about $3.4 billion. Addressing […]
Boston Scientific has wrapped up the previously announced $1.07 billion acquisition of the global surgical business of Israeli medical solutions provider Lumenis. The US medical device manufacturer had signed the deal in March 2021 with an affiliate of Baring Private Equity Asia (BPEA), which owns Lumenis. The BPEA affiliate will retain ownership of Lumenis’ global […]
Boston Scientific has agreed to acquire the global surgical business of Israel-based energy-based medical solutions provider Lumenis for $1.07 billion in cash. In this connection, Boston Scientific has signed a deal with an affiliate of Baring Private Equity Asia (BPEA), which will retain ownership of the global aesthetics and ophthalmology businesses of Lumenis. The surgical […]